Riskpilot← Back to searchSign inGet full accessSENTRUM ØYEKLINIKK AS
ASActiveOrg 984847521Prinsens Gate 67, 7011 TrondheimMedical specialists activities · NACE 8622Est. 20029 employees
Revenue 2025
NOK 10,8M
+12% vs 2024
EBITDA margin
59.5%
+11% vs 2024
Equity ratio
53.6%
Financial strength
Net profit 2025
NOK 5M
+14% vs 2024
| Revenue | NOK 10,8M | +12% |
| EBITDA | NOK 6,4M | +11% |
| Net profit | NOK 5M | +14% |
| Total assets | NOK 11M | +25% |
| Equity | NOK 5,9M | +50% |
| Employees | 9 | — |
Legal name
SENTRUM ØYEKLINIKK AS
Org number
984847521
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
17. september 2002
Share capital
NOK 100 000
Employees
9 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Solomon tsegai teckle
Company purpose
Å forebygge og behandle øyesykdommer, samt hva hermed står i forbindelse med, herunder å delta i andre selskaper med lignende virksomhet.
Address
Prinsens Gate 67, 7011 Trondheim
Phone
+4773990360
Email
post@sentrumoyeklinikk.nhn.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 9 101 | 8 571 | 9 622 | 9 598 | 10 768 |
| Staff expenses | −2 957 | −3 064 | −2 758 | −2 793 | −3 104 |
| EBITDA | 5 135 | 4 497 | 5 843 | 5 747 | 6 406 |
| Depreciation & amort. | −244 | −232 | −163 | −153 | −162 |
| EBIT | 4 891 | 4 265 | 5 680 | 5 594 | 6 244 |
| Net financials | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 4 890 | 4 264 | 5 680 | 5 586 | 6 348 |
| Tax | 1 076 | 938 | 1 249 | 1 230 | 1 396 |
| Net profit | 3 814 | 3 326 | 4 430 | 4 355 | 4 951 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 5 336 | 5 749 | 7 487 | 8 799 | 10 971 |
| Equity | 815 | 1 141 | 2 571 | 3 927 | 5 878 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 4 457 | 4 548 | 4 851 | 4 805 | 5 002 |
| Total debt | 4 521 | 4 608 | 4 915 | 4 872 | 5 093 |
EBITDA margin
59.5%
This company
15.8%
Market median
+277% vs market
20212025
Equity ratio
53.6%
This company
38.2%
Market median
+40% vs market
20212025
Return on equity
84.2%
This company
18.4%
Market median
+358% vs market
20212025
Net profit margin
46.0%
This company
8.1%
Market median
+468% vs market
20212025
Asset turnover
0.98×
This company
1.12×
Market median
+13% vs market
20212025
Debt / equity
0.87×
This company
0.62×
Market median
+40% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
ST Chief Executive Officer | Chief Executive Officer | 2002 |
NJ Deputy Member | Deputy Member | 2002 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SENTRUM ØYEKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Solomon Tsegai Teckle | Chief Executive Officer | 0 companies |
| Nils-Peter Johansson | Deputy Member | 0 companies |